On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 09:47 Today
- Ginkgo Bioworks rises 21.8%
- 08/15/22
- Ginkgo Bioworks and XpresSpa awarded airport COVID surveillance program
- 08/11/22
- Ginkgo Bioworks rises 20.0%
- 08/11/22
- Ginkgo Bioworks rises 17.3%
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 07/28/22
- User reports indicate problems at Zoom, Downdetector says
- 06/22/22
- Zoom Video introduces Zoom One offering
- 06/06/22
- Zoom Video announces Greg Tomb as president
- 08/15/22
- Tiger Global buys Alphabet Class A, exits Zoom Video in Q2
- 06/08/22
- Snowflake CEO: Our customers are not falling off a cliff
- 06/07/22
- Snowflake launches new Cybersecurity workload
- 05/30/22
- Fly Intel: Top five weekend stock stories
- $26.13 /
+10.135 (+63.36%) - 11:32 Today
- Bed Bath & Beyond trading resumes
- 11:27 Today
- Bed Bath & Beyond trading halted, volatility trading pause
- 08/15/22
- Bed Bath & Beyond up another 16.5% amid increase in StockTwits message volume
- 08/03/22
- Bed Bath & Beyond down 3% to $5.62 after Bloomberg report on credit talks
- 08:34 Today
- Walmart says Q3 back to school season off to solid start
- 08:18 Today
- Walmart says cancelled billions of dollars in orders to align inventory
- 07:23 Today
- Walmart says actions to improve inventory put pressure on full-year outlook
- 07:17 Today
- Walmart sees second half headwind of $2.1B
- $330.11 /
+15.84 (+5.04%) - 09:58 Today
- Home Depot says comparable sales growth 7.1% in July
- 09:12 Today
- Home Depot says all U.S. regions delivered positive comps in Q2
- 07/28/22
- Home Depot announces latest carbon emission reductions
- 06/27/22
- Home Depot adopts HPE GreenLake for Aruba Networking, Aruba ESP
- 09:08 Today
- WWE announces record first-day ticket sales for WrestleMania 39
- 07:05 Today
- WWE raises FY22 adjusted OIBDA view to $370M-$385M from $360M-$375M
- 07:04 Today
- WWE sees Q3 adjusted OIBDA $70M-$80M
- 05:57 Today
- WWE: Probe of Vince McMahon 'substantially complete'
- 09:47 Today
- ZipRecruiter falls -9.7%
- 06/21/22
- ZipRecruiter nnounced that the company is set to join the Russell 3000
- 06/17/22
- ZipRecruiter rises 15.6%
- 06/16/22
- ZipRecruiter announces $150M increase to share buyback program
- 08/15/22
- Elliott buys Pinterest, exits Twitter in Q2
- 08/15/22
- Lone Pine buys Booking, exits Snap in Q2
- 08/07/22
- Fly Intel: Top five weekend stock stories
- 08/02/22
- PayPal up 13% after earnings, buyback, pact with Elliott
- 08/04/22
- Visa, RevoluPAY enter agreement for affiliate membership
- 07/28/22
- Bread Financial, AAA sign multi-year agreement
- 07/26/22
- Visa reports Q3 payments volume up 12% y/y
- 07/14/22
- Verizon Visa Card holders can earn 4% rewards on gas purchases
- 08/05/22
- Ebang to launch Ebonex crypto-linked payment cards powered by MasterCard
- 08/04/22
- MasterCard directing institutions to suspend acceptance at TrafficJunky
- 07/28/22
- MasterCard still seeing consumers as 'generally resilient,' says CEO
- 07/28/22
- MasterCard: 'We believe in competition, level playing field'
- 08/02/22
- Matson falls -9.7%
- 06/22/22
- Matson raises quarterly dividend to 31c per share from 30c
- 08:16 Today
- Nielsen, Amazon.com sign pact to measure Prime Video's NFL TNF telecasts
- 08/15/22
- Lone Pine buys Booking, exits Snap in Q2
- 08/15/22
- David Tepper's Appaloosa buys Salesforce, exits Nordstrom in Q2
- 08/12/22
- Soros adds Biohaven, exits Lucid in Q2
- 07:05 Today
- FDA accepts submission of sNDA for LYNPARZA prednisolone combo for mCRPC
- 05:20 Today
- AstraZeneca's Lynparza combination granted Priority Review in U.S.
- 08/15/22
- AstraZeneca says Enhertu delayed disease progression in DESTINY-Breast02 trial
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 08/15/22
- Ideaya Biosciences down 34% after GSK waived option on IDE397
- 08/11/22
- Haleon says it is not a party to any Zantac claims
- 08/11/22
- GSK says no new 'material developments' related to Zantac litigation
- 08/11/22
- Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation
- 08/04/22
- 3M commences splitoff exchange offer for food safety business
- 07/31/22
- Fly Intel: Top five weekend stock stories
- 07/26/22
- 3M provides update on food safety transaction with Neogen
- 07/26/22
- Aearo Technologies initiates chapter 11 proceedings to resolve litigation
- 08/01/22
- BMW recalls certain i4, iX vehicles in North America over battery issues
- 07/06/22
- Northvolt raises $1.1B to support factory rollout plans in Europe
- 06/30/22
- BMW expands operating system, will integrate Android Automotive OS
- 05/02/22
- Magna begins production of mild hybrid transverse transmission for BMW
- 08/02/22
- U.S. video game consumer spending fell 13% y/y in Q2, says NPD
- 08/02/22
- Logitech G, Tencent announce handheld cloud gaming partnership
- 07/20/22
- 'Minecraft' developer says NFTs, blockchain tech not allowed in the game
- 07/15/22
- Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD
- 12:00 Today
- Blend Labs rises 23.0%
- 10:00 Today
- Blend Labs rises 26.4%
- 04/01/22
- Blend Labs falls -15.9%
- 04/01/22
- Blend Labs falls -14.6%
- 12:00 Today
- IonQ rises 25.8%
- 10:00 Today
- IonQ rises 25.0%
- 09:47 Today
- IonQ rises 15.1%
- 07/20/22
- IonQ announces expansion with first European and Israeli entities
- 07/01/22
- Global-e Online closes acquisition of Borderfree business from Pitney Bowes
- 06/21/22
- Global-e Online to acquire Borderfree unit from Pitney Bowes for $100M
- 04/27/22
- Global-e Online and Klarna expand global partnership to Canada
- 08/15/22
- Third Point adds Disney, exits Intuit in Q2
- 06/14/22
- Sema4 Holdings announces departure of CFO Isaac Ro and succession plan
- 06/01/22
- Sema4, Avera Health announce data-driven study to advance cancer treatment
- 05/02/22
- Sema4 completes acquisition of GeneDx from Opko Health
- 10:14 Today
- Albireo Pharma cuts FY22 Bylvay revenue guidance to $24M
- 08/15/22
- Albireo Pharma sees sufficient cash, equivalents into 2024
- 08/10/22
- Albireo Pharma appoints Habib Dable, Susan Alesina to board
- 07/06/22
- Albireo Pharma's Bylvay meets primary endpoints in published study on PFIC
- 08/15/22
- AMMO trading resumes
- 08/15/22
- AMMO to separate ammunition, marketplace businesses into two public companies
- 08/15/22
- AMMO trading halted, news pending
- 08/01/22
- FBI reports 2.4M NICS firearm background checks in July
- 10:00 Today
- Bloom Energy falls -10.0%
- 06/23/22
- Bloom Energy installs one megawatt of solid oxide fuel cells at Ferrari factory
- 05/25/22
- LSB Industries launches green ammonia project
- 04/21/22
- Bloom Energy, EQT close CTA pact for 'responsibly sourced natural gas'
- 10:00 Today
- Compass falls -13.5%
- 09:47 Today
- Compass falls -12.3%
- 08/15/22
- Compass announces cost reduction program with approximately $320M in savings
- 06/14/22
- Compass Inc trading resumes
- 09:29 Today
- Lumentum: Will take ~24 months to return to prior LT model of 50%+ gross margins
- 08/15/22
- IPG Photonics sells telecom transmission product lines to Lumentum
- 07/29/22
- Lumentum, NeoPhotonics announce receipt of antitrust clearance in China
- 04/05/22
- Lumentum, Ambarella announce a new joint reference design Vision-D
- 06/28/22
- Genius Sports launches integrity intelligence platform with Clue
- 06/06/22
- Genius Sports rises 16.8%
- 04/05/22
- Genius Sports announces partnership with Liga MX franchise Club Necaxa
- 04/04/22
- Genius Sports obtains regulatory approval for Ontario launch
- 08/04/22
- Premier raises quarterly dividend 5% to 21c per Class A share
- 07/25/22
- TruMed Systems awarded group purchasing agreement with Premier
- 07/20/22
- Tela Bio awarded Synthetic Bioabsorbable products agreement with Premier
- 07/13/22
- SodexoMagic awarded agreement for on-site management services with Premier
- 08:19 Today BTIG
- Ginkgo Bioworks price target raised to $6 from $5 at BTIG
- 06:56 Today Raymond James
- Ginkgo Bioworks price target raised to $14.50 from $11.50 at Raymond James
- 07/26/22 William Blair
- Zymergen buyout deal 'best case scenario,' says William Blair
- 07/26/22 JPMorgan
- Zymergen upgraded to Neutral from Underweight at JPMorgan
- 05:10 Today Citi
- Zoom Video downgraded to Sell from Neutral at Citi
- 08/04/22 MKM Partners
- Zoom Video initiated with a Buy at MKM Partners
- 08/03/22 Craig-Hallum
- RingCentral price target lowered to $110 from $175 at Craig-Hallum
- 07/19/22 Bernstein
- Zoom Video initiated with a Market Perform at Bernstein
- 08:45 Today Barclays
- Snowflake price target raised to $210 from $158 at Barclays
- 06:38 Today Citi
- Citi opens negative Catalyst Watch on Snowflake ahead of earnings
- 06:02 Today UBS
- Snowflake downgraded to Neutral at UBS following field checks
- 05:45 Today UBS
- Snowflake downgraded to Neutral from Buy at UBS
- $26.13 /
+10.135 (+63.36%) - 09:00 Today B. Riley
- B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
- 05:48 Today B. Riley
- Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley
- 08/09/22 Baird
- Baird downgrades Bed Bath & Beyond to sell after 86% two-day rally
- 08/09/22 Baird
- Bed Bath & Beyond downgraded to Underperform from Neutral at Baird
- 11:38 Today Wells Fargo
- Walmart price target raised to $155 from $130 at Wells Fargo
- 07/29/22 BofA
- Amazon price target bumped to $170 at BofA after 'mostly positive' quarter
- 07/28/22 DA Davidson
- Best Buy price target lowered to $88 from $110 at DA Davidson
- 07/28/22 Wells Fargo
- Best Buy price target lowered to $70 from $82 at Wells Fargo
- $330.11 /
+15.84 (+5.04%) - 11:38 Today Wells Fargo
- Home Depot shares 'can work nicely from here,' says Wells Fargo
- 08/11/22 Citi
- Lowe's downgraded to Neutral from Buy at Citi
- 08/09/22 JPMorgan
- Home Depot price target lowered to $311 from $335 at JPMorgan
- 06/22/22 MKM Partners
- Home Depot initiated with a Neutral at MKM Partners
- 07/26/22 Benchmark
- WWE price target raised to $80 from $71 at Benchmark
- 07/25/22 Loop Capital
- Loop Capital upgrades WWE to Buy on rising likelihood of company sale
- 07/25/22 MKM Partners
- WWE price target raised to $79 from $70 at MKM Partners
- 07/25/22 Loop Capital
- WWE upgraded to Buy from Hold at Loop Capital
- 08:41 Today Barclays
- ZipRecruiter price target lowered to $25 from $30 at Barclays
- 06:29 Today Raymond James
- ZipRecruiter price target lowered to $30 from $40 at Raymond James
- 06/29/22 JPMorgan
- ZipRecruiter price target lowered to $19 from $22 at JPMorgan
- 06/09/22 Goldman Sachs
- ZipRecruiter price target lowered to $26 from $30 at Goldman Sachs
- 05:43 Today Daiwa
- PayPal upgraded to Outperform from Neutral at Daiwa
- 08/08/22 Mizuho
- PayPal price target lowered to $118 from $120 at Mizuho
- 08/04/22 BMO Capital
- PayPal price target raised to $124 from $114 at BMO Capital
- 08/04/22 Barclays
- PayPal price target raised to $131 from $125 at Barclays
- 05:44 Today Daiwa
- Visa downgraded to Neutral from Outperform at Daiwa
- 08/03/22 Truist
- PayPal price target raised to $108 from $80 at Truist
- 08/01/22 BMO Capital
- MasterCard price target raised to $422 from $402 at BMO Capital
- 07/29/22 Mizuho
- Visa price target raised to $220 from $215 at Mizuho
- 05:47 Today Daiwa
- MasterCard downgraded to Neutral from Outperform at Daiwa
- 05:44 Today Daiwa
- MasterCard downgraded to Neutral from Outperform at Daiwa
- 08/03/22 Truist
- PayPal price target raised to $108 from $80 at Truist
- 08/01/22 BMO Capital
- MasterCard price target raised to $422 from $402 at BMO Capital
- 07:07 Today Wolfe Research
- Wolfe starts Matson at Underperform, sees 'peak EPS' in 2022
- 06:44 Today Wolfe Research
- Matson initiated with an Underperform at Wolfe Research
- 08/02/22 Stifel
- Matson downgraded to Hold at Stifel with freight rates starting to roll over
- 08/01/22 Stifel
- Matson downgraded to Hold from Buy at Stifel
- 08/15/22 Jefferies
- 1Life Healthcare downgraded to Hold from Buy at Jefferies
- 08/11/22 Craig-Hallum
- Kornit Digital price target raised to $32 from $26 at Craig-Hallum
- 08/10/22 Macquarie
- Macquarie started Coupang at Outperform with $26 target yesterday
- 08/10/22 Oppenheimer
- Trade Desk price target raised to $78 from $60 at Oppenheimer
- 08/05/22 Morgan Stanley
- AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Morgan Stanley
- 08/04/22 Barclays
- AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Barclays
- 08/01/22 JPMorgan
- AstraZeneca price target raised to 12,500 GBp from 12,000 GBp at JPMorgan
- 08/01/22 Deutsche Bank
- AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Deutsche Bank
- 06:11 Today Oppenheimer
- Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer
- 08/15/22 RBC Capital
- Haleon initiated with a Sector Perform at RBC Capital
- 08/15/22 Stifel
- Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in
- 08/12/22 JPMorgan
- Sanofi may not be liable for any Zantac litigation damages, says JPMorgan
- 07/27/22 Deutsche Bank
- 3M price target raised to $148 from $146 at Deutsche Bank
- 07/27/22 Wells Fargo
- 3M price target raised to $144 from $137 at Wells Fargo
- 07/27/22 Mizuho
- 3M price target raised to $140 from $130 at Mizuho
- 07/27/22 Barclays
- 3M price target lowered to $137 from $143 at Barclays
- 08/05/22 Societe Generale
- BMW price target lowered to EUR 110 from EUR 115 at Societe Generale
- 08/05/22 Barclays
- BMW price target lowered to EUR 95 from EUR 100 at Barclays
- 08/05/22 RBC Capital
- BMW price target raised to EUR 107 from EUR 105 at RBC Capital
- 05/18/22 Exane BNP Paribas
- Tesla gets price target cut after losing Exane's 'EV World Cup'
- 08/01/22 Goldman Sachs
- Bilibili received one China game approval for August, says Goldman Sachs
- 07/11/22 Goldman Sachs
- Tencent downgraded to Buy from Conviction Buy at Goldman Sachs
- 07/05/22 Macquarie
- China online gaming re-ratings 'about to begin,' says Macquarie
- 06/28/22 Investec
- Tencent downgraded to Sell from Hold at Investec
- 07/24/22 Keefe Bruyette
- Blend Labs downgraded to Underperform from Market Perform at Keefe Bruyette
- 07/18/22 Piper Sandler
- Blend Labs price target lowered to $2.50 from $3.50 at Piper Sandler
- 07/07/22 KeyBanc
- KeyBanc downgrades Blend Labs to Sector Weight on challenging market conditions
- 07/07/22 KeyBanc
- Blend Labs downgraded to Sector Weight from Overweight at KeyBanc
- 07/15/22 Goldman Sachs
- IonQ price target lowered to $8 from $10 at Goldman Sachs
- 06/08/22 Needham
- Needham starts IonQ at Buy as market leader in ion trap quantum computers
- 06/07/22 Needham
- IonQ initiated with a Buy at Needham
- 05/20/22
- IonQ participates in a conference call with Benchmark
- 07/18/22 Piper Sandler
- Global-e Online price target lowered to $28 from $30 at Piper Sandler
- 07/14/22 Goldman Sachs
- Global-e Online price target raised to $31 from $28 at Goldman Sachs
- 05/17/22 Jefferies
- Global-e Online price target lowered to $31 from $70 at Jefferies
- 05/17/22 Needham
- Global-e Online price target lowered to $25 from $75 at Needham
- 07:43 Today Jefferies
- Jefferies downgrades Sema4 to Hold, halves price target to $2
- 05:50 Today Jefferies
- Sema4 Holdings downgraded to Hold from Buy at Jefferies
- 06/02/22 Goldman Sachs
- Sema4 Holdings reinstated with a Buy at Goldman Sachs
- 05/16/22 Cowen
- Sema4 Holdings price target lowered to $5 from $13 at Cowen
- 08:09 Today Wedbush
- Albireo Pharma price target lowered to $61 from $72 at Wedbush
- 07:34 Today H.C. Wainwright
- Albireo Pharma price target lowered to $54 from $80 at H.C. Wainwright
- 07:08 Today Baird
- Albireo Pharma price target lowered to $40 from $66 at Baird
- 05/17/22 Baird
- Albireo Pharma price target lowered to $66 from $72 at Baird
- 08:54 Today Lake Street
- AMMO price target lowered to $9 from $12 at Lake Street
- 06/30/22 EF Hutton
- AMMO shares should be bought 'aggressively,' says EF Hutton
- 08/17/21 Lake Street
- AMMO price target raised to $12 at Lake Street after beat and raise report
- 08/11/22 BMO Capital
- Bloom Energy price target raised to $29 from $20 at BMO Capital
- 08/11/22 Truist
- Bloom Energy price target raised to $31 from $19 at Truist
- 08/10/22 Raymond James
- Bloom Energy price target raised to $29 from $23 at Raymond James
- 08/10/22 Susquehanna
- Bloom Energy price target raised to $30 from $28 at Susquehanna
- 08:47 Today Barclays
- Compass price target lowered to $5 from $7 at Barclays
- 07/21/22 Morgan Stanley
- Compass downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/16/22 Oppenheimer
- Compass price target lowered to $9 from $14 at Oppenheimer
- 04/22/22 Zelman
- Compass initiated with a Hold at Zelman
- 09/23/21 B. Riley
- Eagle Point Credit resumed with a Buy at B. Riley
- 08/08/22 Craig-Hallum
- Lumentum price target raised to $125 from $115 at Craig-Hallum
- 07/25/22 Barclays
- Lumentum price target lowered to $95 from $100 at Barclays
- 07/14/22 JPMorgan
- Lumentum price target lowered to $100 from $115 at JPMorgan
- 06/06/22 Jefferies
- Service Provider capex should remain resilient, says Jefferies
- 07/07/22 Citi
- Genius Sports price target lowered to $6 from $8 at Citi
- 06/28/22 B. Riley
- Genius Sports price target lowered to $5.50 from $9 at B. Riley
- 06/09/22 Citi
- Genius Sports price target lowered to $8 from $12 at Citi
- 05/25/22 B. Riley
- Genius Sports price target lowered to $9 from $13 at B. Riley
- 05/04/22 Canaccord
- Premier price target lowered to $44 from $47 at Canaccord
- 05/04/22 Piper Sandler
- Premier upgraded to Overweight from Neutral at Piper Sandler
- 04/13/22 Guggenheim
- Premier initiated with a Neutral at Guggenheim
- 03/31/22 Credit Suisse
- Premier assumed with an Underperform at Credit Suisse
- 08/15/22
- Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
- 08/15/22
- Ginkgo Bioworks reports Q2 EPS (41c), consensus (4c)
- 05/16/22
- Ginkgo Bioworks sees FY22 revenue view to $375M-$390M from $325M-$340M
- 05/16/22
- Ginkgo Bioworks reports Q1 revenue $168M, consensus $105.68M
- 06/20/22
- Fly Intel: Top five weekend stock stories
- 05/23/22
- Zoom Video raises FY23 EPS view to $3.70-$3.77 from $3.45-$3.51
- 05/23/22
- Zoom Video sees Q2 EPS 90-92c, consensus 88c
- 05/23/22
- Zoom Video reports Q1 EPS $1.03, consensus 87c
- 05/25/22
- Snowflake reports Q1 EPS (53c), consensus 1c
- 05/25/22
- Notable companies reporting after market close
- 03/02/22
- Snowflake sees FY23 product revenue $1.88B-$1.9B
- 03/02/22
- Snowflake reports Q4 EPS (43c), consensus 3c
- $26.13 /
+10.135 (+63.36%) - 06/29/22
- Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39)
- 06/28/22
- Notable companies reporting before tomorrow's open
- 06/28/22
- Notable companies reporting before tomorrow's open
- 04/13/22
- Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c
- 07:15 Today
- Walmart raises FY23 adjusted EPS view to down 9%-11% from down 10%-12%
- 07:13 Today
- Walmart sees Q3 adjusted EPS down 9%-11%
- 07:07 Today
- Walmart reports Q2 adjusted EPS $1.77 vs. $1.78 last year
- 07/25/22
- Walmart lowers profit outlook for FY23, sees adjusted EPS to decline 10%-12%
- $330.11 /
+15.84 (+5.04%) - 06:06 Today
- Home Depot backs FY22 EPS view up mid-single digits, consensus $16.46
- 06:03 Today
- Home Depot reports Q2 EPS $5.05, consensus $4.95
- 05/17/22
- Home Depot ups FY22 EPS view to up mid single digits from up low single digits
- 05/17/22
- Home Depot reports Q1 EPS $4.09, consensus $3.67
- 07:03 Today
- WWE reports Q2 adjusted EPS 59c vs. 34c last year
- 07/25/22
- WWE reports preliminary Q2 revenue $328M, consensus $311.84M
- 05/05/22
- WWE sees Q2 adjusted OIBDA $80M-$90M
- 05/05/22
- WWE reports Q1 EPS 77c, consensus 61c
- 08/15/22
- ZipRecruiter cuts FY22 revenue view to $883M-$897M from $908M-$922M
- 08/15/22
- ZipRecruiter sees Q3 revenue $217M-$223M, consensus $233.57M
- 08/15/22
- ZipRecruiter reports Q2 EPS 11c, consensus 6c
- 05/11/22
- ZipRecruiter sees FY22 revenue $908M-$922M, consensus $892.98M
- 08/02/22
- PayPal raises FY22 adjusted EPS view to $3.87-$3.97, consensus $3.85
- 08/02/22
- PayPal sees Q3 adjusted EPS 94c-96c, consensus 97c
- 08/02/22
- PayPal reports Q2 adjusted EPS 93c, consensus 86c
- 08/02/22
- Notable companies reporting after market close
- 07/26/22
- Visa reports Q3 EPS $1.98, consensus $1.74
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Visa reports Q2 EPS $1.79, consensus $1.65
- 04/26/22
- Notable companies reporting after market close
- 07/28/22
- MasterCard sees FY22 adjusted revenue up low 20% range, consensus $22.16B
- 07/28/22
- MasterCard sees Q3 adjusted revenue up at high end of low double digits
- 07/28/22
- MasterCard reports Q2 adjusted EPS $2.56, consensus $2.35
- 07/27/22
- Notable companies reporting before tomorrow's open
- 07/19/22
- Matson sees Q2 $9.31-$9.42 vs $3.71 last year
- 02/17/22
- Matson reports Q4 EPS $9.39, one estimate $4.77
- 07/28/22
- Amazon reports Q2 AWS net sales $19.73B vs. $14.81B a year ago
- 07/28/22
- Amazon sees Q3 revenue $125B-$130B, consensus $126.42B
- 07/28/22
- Amazon reports Q2 EPS (20c) with Rivian loss, consensus 13c
- 07/28/22
- Notable companies reporting after market close
- 07/29/22
- AstraZeneca backs FY22 core EPS view up by mid to high twenties percentage
- 07/29/22
- AstraZeneca reports Q2 core EPS $1.72, up 89% year-over-year
- 04/29/22
- AstraZeneca backs FY22 core EPS up by mid to high twenties percentage
- 04/29/22
- AstraZeneca reports Q1 core EPS $1.89, up 20% y/y
- 07/27/22
- GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year
- 04/27/22
- GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER
- 04/27/22
- GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year
- 04/13/22
- GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B
- 07/26/22
- 3M cuts FY22 adjusted EPS view to $10.30-$10.80 from $10.75-$11.25
- 07/26/22
- 3M reports Q2 adjusted EPS $2.48, consensus $2.45
- 07/25/22
- Notable companies reporting before tomorrow's open
- 07/25/22
- Notable companies reporting before tomorrow's open
- 08/15/22
- Blend backs FY22 revenue view $230M-$250M, consensus $232.32M
- 08/15/22
- Blend reports Q2 EPS adjusted EPS (19c), consensus (19c)
- 05/12/22
- Blend Labs backs FY22 revenue view of $230M-$250M, consensus $234.6M
- 05/12/22
- Blend Labs reports Q1 EPS (32c), consensus (19c)
- 08/15/22
- IonQ reports Q2 EPS (1c), consensus (10c)
- 05/16/22
- IonQ reiterates FY22 revenue view $10.2M-$10.7M
- 05/16/22
- IonQ sees Q2 revenue $2.3M-$2.5M
- 05/16/22
- IonQ reports Q1 EPS (2c) vs (6c) last year
- 07:09 Today
- Global-e Online raises FY22 revenue view to $406M-$426M from $383M-$403M
- 07:08 Today
- Global-e Online sees Q3 revenue $99.5M-$102.5M, consensus $93.86M
- 07:06 Today
- Global-e Online reports Q2 EPS (31c), consensus (30c)
- 05/16/22
- Global-e Online sees Q2 revenue $82.5M-$84.5M, consensus $90.26M
- 05/12/22
- Sema4 Holdings raises FY22 revenue $305M-$315M from $215M-$225M
- 05/12/22
- Sema4 Holdings reports Q1 EPS (31c), consensus (31c)
- 03/14/22
- Sema4 Holdings sees FY22 revenue $215M-$225M, consensus $273.57M
- 03/14/22
- Sema4 Holdings reports Q4 EPS (17c), consensus (26c)
- 08/15/22
- Albireo Pharma reports Q2 EPS ($2.04), consensus ($1.65)
- 05/16/22
- Albireo Pharma reports Q1 EPS ($2.19), consensus ($1.85)
- 03/01/22
- Albireo Pharma reports Q4 EPS (57c), consensus ($1.35)
- 08/15/22
- AMMO reports Q1 EPS 9c vs. 13c last year
- 06/29/22
- AMMO sees FY 23 revenue $300M -$310M, consensus $311.77M
- 06/29/22
- AMMO reports FY22 EPS 53c, consensus 35c
- 08/09/22
- Bloom Energy backs FY22 revenue view $1.1B-$1.15B, consensus $1.13B
- 08/09/22
- Bloom Energy reports Q2 adjusted EPS (20c), consensus (17c)
- 08/09/22
- Notable companies reporting after market close
- 05/05/22
- Bloom Energy backs FY22 revenue view of $1.10B-$1.15B, consensus $1.13B
- 08/15/22
- Compass sees FY22 revenue $6.15B-$6.45B, consensus $7.59B
- 08/15/22
- Compass sees Q3 revenue $1.4B-$1.5B, consensus $2.11B
- 08/15/22
- Compass reports Q2 EPS (24c), consensus (14c)
- 05/12/22
- Compass lowers FY22 revenue view to $7.6B-$8.0B from $7.9B-$8.1B
- 08:08 Today
- Eagle Point Credit reports Q2 EPS 43c, consensus 41c
- 05/24/22
- Eagle Point Credit reports Q1 NII 30c, consensus 40c
- 02/17/22
- Eagle Point Credit reports Q4 EPS 37c, consensus 36c
- 07:37 Today
- Lumentum CEO targets double-digit revenue growth in FY23, consensus $1.97B
- 07:32 Today
- Lumentum sees Q1 adjusted EPS $1.45-$1.70, consensus $1.83
- 07:31 Today
- Lumentum reports Q4 adjusted EPS $1.47, consensus $1.33
- 05/04/22
- Lumentum sees Q4 non-GAAP EPS $1.25-$1.40, consensus $1.22
- 07:23 Today
- Genius Sports sees FY22 revenue of approximately $340M, consensus $341.66M
- 07:20 Today
- Genius Sports reports Q2 EPS (2c), consensus (9c)
- 05/12/22
- Genius Sports sees 2023 revenue $430M, consensus $437.43M
- 05/12/22
- Genius Sports sees 2022 revenue $340M, consensus $342.89M
- 06:32 Today
- Premier sees FY23 adjusted EPS $2.63-$2.75, consensus $2.69
- 06:31 Today
- Premier reports Q4 adjusted EPS 61c, consensus 60c
- 05/03/22
- Premier raises FY22 adjusted EPS view to $2.48-$2.58 from $2.45-$2.55
- 05/03/22
- Premier reports Q3 adjusted EPS 57c, consensus 58c
|